Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • NPPA fixes the price...

    NPPA fixes the price of Roseday, Volini Maxx Spray, BCG Vaccine, and more, check out details

    Written by Ruby Khatun Khatun Published On 2018-04-28T17:12:29+05:30  |  Updated On 28 April 2018 5:12 PM IST
    NPPA fixes the price of Roseday, Volini Maxx Spray, BCG Vaccine, and more, check out details

    New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India has fixed/revised ceiling prices/retail prices of 37 formulations under Drugs Prices Control Order, 2013 and withdrawn the Ceiling price of 1 scheduled formulation of Schedule-I under para 19 of Drugs Prices Control Order,2013.


    In its notification, NPPA has fixed the retail prices of 35 formulations under Drugs Prices Control Order, 2013, exclusive of goods and services tax (GST).


    Following are the details:















































































































































































































































    Sl. No.Name of the
    Formulation / Brand Name
    StrengthUnitManufacturer & Marketing CompanyRetail Price
    (Rs.)
    (1)(2)(3)(4)(5)(6)
    1Rosuvastatin + Aspirin + Clopidogrel Capsule (R2 Trio 10)Each hard gelatine capsule contains:
    Rosuvastatin Calcium IP eq. to Rosuvastation 10mg (As film coated tablet)
    Aspirin IP 75mg (As gastro resistant tab)
    Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As film coated tablet)
    1 Capsule M/s Akums Drugs &
    Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd.
    11.70
    2Rosuvastatin + Aspirin + Clopidogrel Capsule (R2 Trio 20)Each hard gelatine capsule contains:
    Rosuvastatin Calcium IP eq. to Rosuvastation 20mg (As film coated tablet)
    Aspirin IP 75mg (As gastro resistant tab)
    Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As film coated tablet)
    1 Capsule M/s Akums Drugs &
    Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd.
    18.00
    3Atorvastatin +
    Clopidogrel Capsule (Stator CV)
    Each hard gelatine capsule contains:
    Atorvastatin Calcium IP eq. to Atorvastatin 10mg (As film coated tablet)
    Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As 2 film coated
    37.5mg each tablet)
    1 CapsuleM/s Windlas Biotech Limited / M/s Abbott
    Healthcare Pvt. Ltd.
    8.394
    4Amoxycillin + Clavulnic Suspension (a) Each 5ml of constituted suspension
    contains:
    Amoxycillin Trihydrate IP eq. to Amoxycillin 400mg, Potassium
    Clavulante Diluted IP eq. to Clavulnic
    Acid 57mg
    (b) One vial of purified water IP Each vail contains: Purified water IP 30ml
    1 MLM/s Akums Drugs &
    Pharmaceuticals Ltd. / M/s IPCA Laboratories
    Limited
    2.91
    5Paclitaxel Injection (Nab-Altaxel 100mg) Each vial contains:
    Paclitaxel IP 100mg Human Albumin IPm q.s.
    1 VialM/s Beta Drugs Limited / M/s Alkem Laboratories Limited 11115.39
    6 Escitalopram +Clonazepam Tablet
    (Szetalo Plus 5)
    Each film coated tablet contains:
    Escitalopram Oxalate eq. to
    Escitalopram 5mg, Clonazepam IP 0.5mg
    1 TabletM/s Tristar Formulations
    Pvt. Ltd. / M/s Abbott
    Healthcare Pvt. Ltd.
    3.83
    7Teneligliptin +
    Metformin Tablet (Terostil M)
    Each uncoated bilayered tablet
    contains:
    Teneligliptin Hydrobromide Hydrate
    eq. to Teneligliptin 20mg Metformin HCl 500mg (SR)
    1 TabletM/s Synokem
    Pharmaceuticals Ltd. / M/s Anthem BioPharma
    Pvt. Ltd.
    9.62
    8Glimepride +
    Metformin Tablet (Glimison-M2 Forte)
    Each uncoated Bilayered tablet contains:
    Glimepride IP 2mg, Metformin Hydrochloride (SR) 1000mg
    1 TabletM/s Unison
    Pharmaceuticals Pvt. Ltd.
    3.88
    9Glimepride +
    Metformin Tablet (Glimison-M1 Forte)
    Each uncoated Bilayered tablet contains:
    Glimepride IP 1mg, Metformin Hydrochloride (SR) 1000mg
    1 TabletM/s Unison
    Pharmaceuticals Pvt. Ltd.
    3.53
    10Metoprolol +
    Amlodipine Tablet (MPROL-AM 25/5)
    Each film coated bilayered tablet contains:
    Metoprolol Succinate ER 25mg Amlodipine Besylate 5mg bilayered
    Tablets
    1 TabletM/s Unison
    Pharmaceuticals Pvt. Ltd.
    1.96
    11Telmisartan +
    Chlorthalidone Tablet (Telmiride – CH 6.25)
    Each uncoated bilayered tablet contains:
    Telmisartan IP 40mg, Chlorthalidone IP 6.25mg Tablets
    1 TabletM/s Windlabs Biotech Pvt.
    Ltd. / M/s Unison
    Pharmaceuticals Pvt. Ltd.
    2.68
    12Telmisartan +
    Chlorthalidone Tablet
    Telmiride – CH 12.50 Tablet
    Each uncoated bilayered tablet contains:
    Telmisartan IP 40mg + Chlorthalidone
    IP 12.50mg Tablets
    1 TabletM/s Windlabs Biotech Pvt.
    Ltd. / M/s Unison
    Pharmaceuticals Pvt. Ltd
    3.21
    13Ferrous + Folic Acid + Elemental Tablet (Tonofolic – XT)Each film coated tablets contains:
    Ferrous Ascorbate eq. to elemental
    Iron 100mg + Folic Acid 1.5mg +
    Elemental Zinc 22.5mg Tablets
    1 TabletM/s Ravenbhel Healthcare
    Pvt. ltd. / M/s Unison
    Pharmaceuticals Pvt. Ltd.
    3.52
    14Voglibose + Glimepride
    + Metformin Tablet (Voglyson GM1)
    Each uncoated bilayered tablet contains:
    Voglibose 0.2mg,
    Glimepride 1mg &
    Metformin Hydrochloride 500mg
    Tablets(SR)
    1 TabletM/s Windlabs Biotech Pvt.
    Ltd. / M/s Unison
    Pharmaceuticals Pvt. Ltd.
    3.21
    15Voglibose + Glimepride
    + Metformin Tablet
    (Voglyson GM2)
    Each uncoated bilayered tablet
    contains:
    Voglibose 0.2mg,
    Glimepride 2mg &
    Metformin Hydrochloride 500mg
    Tablets(SR)
    1 TabletM/s Windlabs Biotech Pvt.
    Ltd. / M/s Unison
    Pharmaceuticals Pvt. Ltd
    3.57
    16Doxorubicin Injection EEach ml contains:
    Doxorubicin Hydrochloride 2mg (Pegylated Liposomal) Water for
    Injection
    1 MLM/s Natco Pharma
    Limited / M/s RPG Life Sciences Ltd.
    694.29
    17Glimiepiride +
    Metformin Tablet
    (GLYCOMET GP 3 Forte)
    Each film coated tablet contains:
    Glimiepiride IP 3mg,
    Metformin Hydrochloride IP 1000mg
    (SR)
    1 Tablet M/s Accent Pharma / M/s USV Private Limited 8.37
    18Rosuvastation +
    Aspirin + Clopidogrel Capsule (Rxtor Gold 10)
    Each hard gelatine capsule contains:
    Rosuvastation Calcium IP 10mg (Aspellets), Aspirin 75mg (as enteric
    coated pellets) & Clopidogrel
    Bisulphate IP 75mg (as pellets)
    1 CapsuleM/s Synokem
    Pharmaceuticals Limited /M/s IPCA Laboratories
    Limited
    11.70
    19Rosuvastation +
    Aspirin + Clopidogrel
    Capsule (Rxtor Gold 20)
    Each hard gelatine capsule contains:
    Rosuvastation Calcium IP 20mg (As
    pellets), Aspirin 75mg (as enteric
    coated pellets) & Clopidogrel
    Bisulphate IP 75mg (as pellets)
    1 CapsuleM/s Synokem
    Pharmaceuticals Limited /
    M/s IPCA Laboratories
    Limited
    18.00
    20Paclitaxel (Protein
    bound Particles) for
    Injectable Suspension
    Each vial contains:
    Paclitaxel IP 100mg Human Albumin
    IP 900mg
    1 VialM/s Emcure
    Pharmaceuticals Ltd.
    11115.39
    21Glimepiride +
    Metformin Tablet
    (Glimy M 0.5mg)
    Each uncoated bilayered Tablet contains:
    Glimepiride IP 0.5mg
    Metformin Hydrochloride IP 500mg(ER)
    1 TabletM/s Pure & Cure
    Healthcare Pvt. Ltd. / M/s Dr. Reddy’s Laboratories
    Limited
    2.22
    22Gliclazide + Metformin
    Tablet (Glizest M)
    Each uncoated tablet contains:
    Gliclazide IP 80mg,
    Metformin Hydrochloride IP 500mg
    1 Tablet M/s Pharmafabrikon 4.88
    23Doxorubicin
    Hydrochloride
    liposomal Injection.
    (2mg/ml)(20mg/vial) 10ml
    Each ml contains:
    Doxorubicin Hydrochloride IP 2mg (As
    pegylated liposomal) Water for
    Injection
    1 MLM/s Natco Pharma
    Limited / M/s Cadila
    Healthcare Limited
    694.29
    24Teneligliptin +
    Metformin Tablet
    Each uncoated bilayered tablet
    contains:
    Teneligliptin Hydrobromide Hydrate
    eq. to Teneligliptin 20mg
    Metformin HCl 1000mg (ER)
    1 TabletM/s Glenmark
    Pharmaceuticals Ltd. / M/s Koye
    Pharmaceuticals Private
    Limited
    10.87
    25Rosuvastatin + Aspirin Capsules (Roseday A 20)Each hard gelatine capsule contains:
    Rosuvastatin Calcium IP eq. to Rosuvastatin 20mg (As pellets),
    Aspirin IP 75mg (As Enteric Coated
    pellets IP),
    1 CapsuleM/s Synokem
    Pharmaceuticals Ltd. / M/s USV Private Limited
    7.80
    26Metformin +
    Glimepiride Tablet
    (Glucoryl – M 0.5)
    Each uncoated bilayer tablet contains:
    Metformin Hydrochloride IP 500mg
    (As prolonged Release form),
    Glimepiride IP 0.5mg
    1 TabletM/s Alkem Laboratories
    Ltd
    2.22
    27Amoxycillin +
    Clavulanic Dry Syrup (Trimox CV Forte)
    Each 5ml of re-constituted Suspension
    contains:
    Amoxycillin Trihydrate IP eq. to
    Amoxycillin 400mg,
    Potassium Clavulanic Diluted IP eq. to Clavulanic Acid 57mg
    1 MLM/s Malik Life Sciences Pvt. Ltd. / M/s Mapra Laboratories Pvt. Ltd. 2.91























































































    Sl. NoName of the
    Formulation / Brand Name
    StrengthUnitManufacturer & Marketing CompanyRetail Price
    (Rs.)
    (1)(2)(3)(4)(5)(6)
    1Diclofenac + Methyl Salcylate + Menthol
    (Volini Maxx Spray in
    15gm Pack)
    contains:
    Diclofenac Diethylamine BP 2.32%
    w/w (eq. to Diclofenac Sodium 2%
    w/w),
    Methyl Salcylate IP 10% w/w &
    Menthol IP 5% w/w
    15 GMM/Sun Pharmaceuticals
    Industries Ltd.
    93.75
    2Diclofenac + Methyl
    Salcylate + Menthol
    (Volini Maxx Spray in
    30gm Pack)
    contains:
    Diclofenac Diethylamine BP 2.32%
    w/w (eq. to Diclofenac Sodium 2%
    w/w),
    Methyl Salcylate IP 10% w/w &
    Menthol IP 5% w/w
    30 GMM/Sun Pharmaceuticals
    Industries Ltd.
    187.50
    3Diclofenac + Methyl
    Salcylate + Menthol
    (Volini Maxx Spray in
    40gm Pack)
    contains:
    Diclofenac Diethylamine BP 2.32%
    w/w (eq. to Diclofenac Sodium 2%
    w/w),
    Methyl Salcylate IP 10% w/w &
    Menthol IP 5% w/w
    40 GMM/Sun Pharmaceuticals
    Industries Ltd.
    231.25
    4Diclofenac + Methyl
    Salcylate + Menthol
    (Volini Maxx Spray in
    60gm Pack)
    contains:
    Diclofenac Diethylamine BP 2.32%
    w/w (eq. to Diclofenac Sodium 2%
    w/w),
    Methyl Salcylate IP 10% w/w &
    Menthol IP 5% w/w
    60 GMM/Sun Pharmaceuticals
    Industries Ltd.
    318.75
    5Atorvastatin + Aspirin
    + Clopidogrel capsule
    Each hard gelatin capsule contains:
    Atorvastatin Calcium IP eq. to
    Atorvastatin 10mg (As granules)
    Aspirin IP 75mg (As EC tablet),
    Clopidogrel Bisulphate IP eq. to
    Clopidogrel 75mg (as two film coated
    tablets)
    1 CapsuleM/s GKM New Pharma /
    M/s Cadila Healthcare Ltd.
    4.12
    6Atorvastatin + Aspirin
    + Clopidogrel capsule
    Each hard gelatin capsule contains:
    Atorvastatin Calcium IP eq. to
    Atorvastatin 20mg (As granules)
    Aspirin IP 75mg (As EC tablet), Clopidogrel Bisulphate IP eq. to
    Clopidogrel 75mg (as to film coated
    tablets)
    1 CapsuleM/s GKM New Pharma /
    M/s Cadila Healthcare Ltd.
    5.56
    7Atorvastatin + Aspirin
    + Clopidogrel capsule
    Each hard gelatin capsule contains:
    Atorvastatin Calcium IP eq. to
    Atorvastatin 10mg (As granules)
    Aspirin IP 75mg (As EC tablet),
    Clopidogrel Bisulphate IP eq. to
    Clopidogrel 75mg (as two film coated
    tablets)
    1 CapsuleM/s Synokem
    Pharmaceuticals Ltd. /
    M/s Eris Lifesciences
    Limited
    4.12
    9Atorvastatin + Aspirin
    + Clopidogrel capsule
    Each hard gelatin capsule contains:
    Atorvastatin Calcium IP eq. to
    Atorvastatin 20mg (As granules)
    Aspirin IP 75mg (As EC tablet),
    Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (as two film coated tablets)
    1 CapsuleM/s Synokem
    Pharmaceuticals Ltd. /
    M/s Eris Lifesciences
    Limited
    5.56


    As per the notification the drug pricing regulator has also revised the ceiling prices of two formulations. Following are the details:


































    Sl. NoName of the
    Scheduled
    Formulation
    Dosage form
    & Strength
    UnitCeiling
    Price (Rs.)
    Review Order
    number and date
    Existing SO
    number and date
    (1)(2)(3)(4)(5)(6)(7)
    1PhenytoinOral Liquid
    30mg/5 ml
    1 ML0.2931015/38/2017-
    Pricing dated
    09.02.2018
    1461(E) dated
    02.04.2018 (at Sl.
    No. 646)




























    Sl.
    No.
    Name of the
    Scheduled
    Formulation
    Dosage form & StrengthUnitCeiling
    Price (Rs.)
    (1)(2)(3)(4)(5)
    1BCG VaccineEach dose5.59


    In a separate notification, NPPA has withdrawn the ceiling price of Ferrous Salt(A) + Folic acid (B) - (100mg + 500mcg) Tablet after Bochem Healthcare Pvt Ltd prayed to the NPPA for upward revision of the ceiling prices of


    (i) Ferrous Salt (A) + Folic acid (B) – 100 mg(A) + 500mcg(B) Tablet and
    (ii) Ferrous Salt (A) + Folic acid (B) – 45 mg(A) + 400mcg(B) Tablet

    stating that the price fixed by the NPPA are unviable. The firm also claimed that the 98 percent of the supply is for NRHM.


    The Authority noted that the Hon’ble High Court of Madhya Pradesh at Jabalpur vide its order dated 19.03.2018 in WP 1550/2018 in the matter of Bochem Healthcare Pvt Ltd. Vs Union of India has given direction : “let decision be taken reviewing the notification dated 20.09.2017 within two weeks on or before 9.4.2018”.


    The Hon’ble High Court has granted additional time for review at the request of the NPPA. However the petitioner has in its petition to the Hon’ble Court stated that the grievance does not relate to 45 mg tablet as it is competitively placed.


    The authority has also noticed that the ceiling price of lower strength is more than the ceiling prices of higher strength. Therefore, the NPPA in its 188th Authority meeting held on 23-4-2018, decided that ceiling price may be fixed/revised under para 19 of the DPCO 2013 considering the petition and grievances of Bochem Healthcare Pvt Ltd, decided to withdraw the notification in respect of Ferrous Salt(A) + Folic acid (B) - (100mg + 500mcg) Tablet.


    Below are the attached notifications


    http://www.nppaindia.nic.in/ceiling/press27Apr18/RetailPrices(27).pdf


    http://www.nppaindia.nic.in/ceiling/press27Apr18/RetailPrices(8).pdf


    http://www.nppaindia.nic.in/ceiling/press27Apr18/CeilingPrices(1).pdf


    http://www.nppaindia.nic.in/ceiling/press27Apr18/CeilingPrices(1)-4.pdf


    http://www.nppaindia.nic.in/ceiling/press27Apr18/CeilingPrices(1)-5.pdf

    BCG Vaccineceiling pricesDepartment of PharmaceuticalsDrugs Prices Control OrderfixesGovernment of IndiaMinistry of Chemicals and FertilizersNational Pharmaceutical Pricing AuthorityNPPApriceRetail PricesRosedayVolini Maxx Spray

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok